NEOSPORIN SUMMARY
NEOSPORIN® OPHTHALMIC OINTMENT STERILE (neomycin and polymyxin B sulfates and bacitracin zinc ophthalmic ointment, USP)
NEOSPORIN OPHTHALMIC OINTMENT (neomycin and polymyxin B sulfates and bacitracin zinc ophthalmic ointment) is a sterile antimicrobial ointment for ophthalmic use. Each gram contains: neomycin sulfate equivalent to 3.5 mg neomycin base, polymyxin B sulfate equivalent to 10,000 polymyxin B units, bacitracin zinc equivalent to 400 bacitracin units, and white petrolatum, q. s. Neomycin sulfate is the sulfate salt of neomycin B and C, which are produced by the growth of Streptomyces fradiae Waksman (Fam. Streptomycetaceae). It has a potency equivalent of not less than 600 µg of neomycin standard per mg, calculated on an anhydrous basis.
NEOSPORIN Ophthalmic Ointment is indicated for the topical treatment of superficial infections of the external eye and its adnexa caused by susceptible bacteria. Such infections encompass conjunctivitis, keratitis and keratoconjunctivitis, blepharitis and blepharoconjunctivitis.
|
|
NEWS HIGHLIGHTS
Clinical Trials Related to Neosporin (Neomycin / Polymyxin B / Bacitracin Ophthalmic)
Left Ventricular Septum Pacing in Patients by Transvenous Approach Through the Inter-ventricular Septum [Recruiting]
Cardiac pacing is the only effective treatment for symptomatic bradycardia. The right
ventricular apex (RVA) has become the most frequently used ventricular pacing site. However,
RVA pacing has been shown to cause left ventricular (LV) dyssynchrony wich can lead to LV
dysfunction and development of heart failure. Recent studies in animals have demonstrated
that pacing at the LV septum induces significantly less ventricular dyssynchrony than RVA
pacing and is able to improve LV function to a similar degree as biventricular (BiV) pacing.
In addition it was shown that a LV septum lead can be placed permanently by driving a lead
with extended helix from the RV side through the inter-ventricular septum into the LV
endocardial layer. This was shown to be a feasible and safe procedure and lead stability was
shown during four months of follow-up in otherwise healthy and active canines. LV septum
pacing may therefore be a good treatment alternative in patients with symptomatic
bradycardia, as well as patients with an indication for cardiac resynchronization therapy
(CRT). The purpose of this study is to translate the findings from preclinical studies to
the clinical situation by investigating the feasibility, long-term lead stability and safety
of LV septum pacing by transvenous approach through the inter-ventricular septum in
patients.
Trial in Cardiac Resynchronization Therapy (CRT) Pacemakers and Dual Chamber (DDD) Pacemakers: Right Ventricular Apex Versus High Posterior Septum [Recruiting]
In heart failure patients we hypothesised that right ventricular high posterior septum is
superior to right ventricular apex in CRT and DDD pacemaker. In two separate trials we
prospectively randomized the right ventricular lead placement to find evidence of
differences in heart failure symptoms (NYHA-class), 6 minute hall walk and echocardiographic
measurements of reverse remodelling and dyssynchrony.
Clearance of Nasal Staphylococcus Aureus With Triple Antibiotic Ointment [Recruiting]
Staphylococcus aureus, a bacteria that lives commonly in the anterior nostrils, is seen in
about 30% of healthcare workers. Applying mupirocin ointment, a prescription, to the
nostrils twice daily for 5 days is the current standard of care for treatment to clear this
bacteria. This research study is designed to determine the rate of clearance of this
bacteria in healthcare workers who are carriers when using triple antibiotic ointment
instead of mupirocin ointment.
Tissue Characterization in Teeth Treated With a Regeneration Protocol [Recruiting]
The purpose of the investigators study is to characterize the composition of the hard and
soft tissues present in root canals of teeth previously diagnosed with necrotic pulps and
incomplete root formation and treated with a triple antibiotic regeneration protocol. The
investigators hypothesis is that treatment of teeth with necrotic pulps and immature apices
with triple antibiotic paste will stimulate continued root formation by the deposition of
dentin at the root apices. The primary outcome measure will be histological identification
of mineralized tissue and adherent cells in the apical third of these teeth.
Use of Ointments in Prevention of Catheter Related Infections in PD [Recruiting]
Peritoneal dialysis (PD) is used for the treatment of end-stage renal disease in
approximately 25% of patients requiring dialysis in Canada. The most common complication is
bacterial infection or ‘peritonitis’. Peritonitis causes severe acute abdominal pain and may
lead to failure of peritoneal dialysis treatment, hospitalization or death, particularly if
left untreated. Amongst the strategies used to prevent peritonitis, patients are instructed
on the regular use of a prophylactic ointment around the point where the catheter exits from
the body. At the present time most centers in Canada routinely prescribe mupirocin ointment
for use at the exit site, however newer ointments have become available. One such ointment
is Polysporin Triple. The aim of this study is to determine if catheter related infections
can be significantly reduced by the routine application of Polysporin Triple in comparison to
mupirocin ointment. A multi-centre, randomized, double blind, controlled study is proposed.
Participants will be randomized to either mupirocin or Polysporin Triple and followed for 18
months or until the first catheter related infection, death or catheter removal. The
difference in catheter related infection rates will be compared between the two groups. We
anticipate the results of this study will allow clinicians to prescribe the ointment most
likely to reduce infections. By doing so this will reduce the complication rate associated
with peritoneal dialysis and, ultimately improve survival.
Reports of Suspected Neosporin (Neomycin / Polymyxin B / Bacitracin Ophthalmic) Side Effects
OFF Label USE (22),
Drug Hypersensitivity (20),
Rash (16),
Product Quality Issue (9),
Hypersensitivity (8),
Pruritus (7),
NO Adverse Event (7),
Skin Exfoliation (6),
Urticaria (6),
Blister (6), more >>
|
|
|
|
Page last updated: 2006-10-03
|